News Saniona postpones 2020 year-end financial report due to restatement and re-audit of prior period financial statements in line with U.S. PCAOB audit standards Continue Reading Previous Bright Minds Biosciences Inc. Announces Marketed Public OfferingNext Admission to Trading on Euronext Brussels Related Stories News Benchmark Corp. brings Hunters’ leading open XDR platform to Canadian market News Zealand Pharma Hosts Conference Call on March 11 at 4 pm CET (10am ET) to Present Full Year Results for 2020 News ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference News MDxHealth Reports Financial Year 2020 Results and Provides Outlook for 2021 News Santhera Announces Completion of First 6-Month Period of Pivotal VISION-DMD Trial with Vamorolone in Duchenne Muscular Dystrophy News Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
